Optimising the Synthesis and QC of [177Lu]Lu-PSMA I&T for Prostate Cancer Therapy

被引:0
|
作者
Hong, K. [2 ]
Fincher, L. [1 ]
Browne, E. [1 ]
机构
[1] St George Hosp, Kogarah, NSW, Australia
[2] Prince Wales Hosp, Randwick, NSW, Australia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P68
引用
收藏
页码:53 / 54
页数:2
相关论文
共 50 条
  • [1] Improved quality control of [177Lu]Lu-PSMA I&T
    Kraihammer, Martin
    Garnuszek, Piotr
    Bauman, Andreas
    Maurin, Michael
    Lafont, Manuel Alejandre
    Haubner, Roland
    von Guggenberg, Elisabeth
    Gabriel, Michael
    Decristoforo, Clemens
    EJNMMI RADIOPHARMACY AND CHEMISTRY, 2023, 8 (01)
  • [2] Improved quality control of [177Lu]Lu-PSMA I&T
    Martin Kraihammer
    Piotr Garnuszek
    Andreas Bauman
    Michael Maurin
    Manuel Alejandre Lafont
    Roland Haubner
    Elisabeth von Guggenberg
    Michael Gabriel
    Clemens Decristoforo
    EJNMMI Radiopharmacy and Chemistry, 8
  • [3] Hematotoxicity and Nephrotoxicity in Prostate Cancer Patients Undergoing Radioligand Therapy with [177Lu]Lu-PSMA I&T
    Hartrampf, Philipp E.
    Weinzierl, Franz-Xaver
    Serfling, Sebastian E.
    Pomper, Martin G.
    Rowe, Steven P.
    Higuchi, Takahiro
    Seitz, Anna Katharina
    Kuebler, Hubert
    Buck, Andreas K.
    Werner, Rudolf A.
    CANCERS, 2022, 14 (03)
  • [4] Matched-pair analysis of [177Lu]Lu-PSMA I&T and [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
    Philipp E. Hartrampf
    Franz-Xaver Weinzierl
    Andreas K. Buck
    Steven P. Rowe
    Takahiro Higuchi
    Anna Katharina Seitz
    Hubert Kübler
    Andreas Schirbel
    Markus Essler
    Ralph A. Bundschuh
    Rudolf A. Werner
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 3269 - 3276
  • [5] Matched-pair analysis of [177Lu]Lu-PSMA I&T and [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
    Hartrampf, Philipp E.
    Weinzierl, Franz-Xaver
    Buck, Andreas K.
    Rowe, Steven P.
    Higuchi, Takahiro
    Seitz, Anna Katharina
    Kuebler, Hubert
    Schirbel, Andreas
    Essler, Markus
    Bundschuh, Ralph A.
    Werner, Rudolf A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (09) : 3269 - 3276
  • [6] Radioligand Therapy with [177Lu]Lu-PSMA I&T in the Elderly - Safety, Efficacy and Prognosticators of Survival
    Weber, S.
    Seitz, A.
    Kuebler, H.
    Buck, A. K.
    Werner, R. A.
    Hartrampf, P. E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S151 - S151
  • [7] Identification of [177Lu]Lu-PSMA I&T, [177Lu]LuCl3 and [177Lu] Lu-DTPA by a single reversed-phase TLC
    Cucchi, C.
    Bogni, A.
    Mainente, M.
    Beretta, C.
    Kirienko, M.
    Seregni, E.
    Pascali, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S666 - S666
  • [8] [177LU]LU-PSMA I&T: DEVELOPMENT OF A MULTIPLE-PATIENT DOSE PRODUCTION METHOD
    Walker, A.
    Rivinoja, D.
    Zia, N.
    Seale, J.
    Santamaria, J.
    Santamaria, G.
    Lengkeek, N.
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 35 - 35
  • [9] Quantifying the impact of residual activity on therapeutic index: an updated dosimetric comparison between [177Lu]Lu-PSMA-10.1 and [177Lu]Lu-PSMA I&T
    Rinscheid, A.
    Dierks, A.
    Kircher, M.
    Pfob, C.
    Bundschuh, R. A.
    Lapa, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S811 - S812
  • [10] Dual Radionuclide Therapy: The Synergistic Effects of [161Tb]Tb-PSMA and [177Lu]Lu-PSMA in Advanced Prostate Cancer Post [177Lu]Lu-PSMA Failure
    Abdlkadir, Ahmed Saad
    Abufara, Alaa
    Al-Ibraheem, Akram
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 58 (06) : 381 - 382